Physician profile
Stan Mathioulakis
NPI 1912080847
$2,329.34
in general payments reported to CMS, 2019-2025
17 companies · $48.54 in 2025
The $48.54 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $543 · 2021: $385 · 2022: $311 · 2023: $316 · 2024: $487 · 2025: $48.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $857.84 | 2021-2025 | |
| Glaxosmithkline, LLC. | $324.84 | 2019-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $255.92 | 2020-2021 | |
| Amarin Pharma, INC. | $165.56 | 2019-2020 | |
| Teleflex LLC | $162.67 | 2024 | Urolift |
| E.R. Squibb & Sons, L.L.C. | $126.08 | 2019-2022 | |
| Exact Sciences Corporation | $90.11 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $79.29 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $50.64 | 2019 | |
| Abbott Laboratories | $45.51 | 2021 | |
| Sanofi Pasteur INC. | $43.28 | 2019 | |
| Gilead Sciences, INC. | $33.33 | 2020-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.07 | 2022 | |
| Merck Sharp & Dohme LLC | $23.48 | 2021 | |
| Vertiflex, INC. | $18.55 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $12.79 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stan Mathioulakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.